Monthly Archives: November 2013

Featured Stories

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Actos Bladder Cancer Lawsuits Continue, New Complaint Filed by Tennessee Resident

Actos bladder cancer lawsuits continue, with a new complaint filed by a resident of Tennessee. The national law firm, Parker Waichman LLP, represents the Tennessee man who alleges that Actos caused his bladder cancer.

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Lawsuits filed by alleged victims of DePuy Orthopaedics’ recalled ASR hip replacement devices continue to pile up in the multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio. Most recently, a woman from Pryor, Oklahoma, filed suit alleging complications caused by a DePuy ASR hip implant ...

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Two Men Found Dead of Carbon Monoxide Poisoning

Two Men Found Dead of Carbon Monoxide Poisoning at Long Island, New York Auto Shop

Two men were found dead of apparent carbon monoxide poisoning in a Holbrook, New York, auto-detailing shop Thursday night, Suffolk County police say.

Read More

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Be Careful When Shopping for Toys This Holiday Season


Consumer experts warn shoppers to be aware this holiday season of dangerous toys that are still on store shelves and which are putting children at risk of injury. The U.S. Public Interest Research Group (PIRG) found that hazardous toys are … Continue reading

Posted in Children's Toys, Consumer Fraud, Defective Products, Health Concerns |

FDA Deems Hospira Recall of its GemStar Infusion System a Class I


The U.S. Food and Drug Administration (FDA) just announced a Class I recall of Hospira Inc.’s GemStar Infusion System, over a pressure sensor calibration drift. The FDA’s Class I recall designation means that the situation is one in which there … Continue reading

Posted in Defective Medical Devices, Defective Products |

FDA Reviewing Efficacy of “Morning After Pill” in Women Weighing Over 165 Pounds


United States health regulators just announced that they are reviewing the efficacy of Plan B emergency contraceptive pills as they may not offer the same benefits in women who weigh more than 165 pounds. In the U.S., the Plan B … Continue reading

Posted in Health Concerns, Pharmaceuticals |

LG TVs Spying on Consumers


Recently, the maker of LG Electronics’ Smart TV admitted to collecting information on consumers’ viewing habits, apparently without consumer knowledge. LG’s new line of Smart TVs collect viewer data to customize the advertising seen on their screens, according to Law … Continue reading

Posted in Consumer Fraud |

Mental Health Risks Tied to Steroid Injections Meant to Stop Premature Birth


A new study reveals that steroid injections used to prevent premature birth might increase future risks of behavioral and emotional problems in the developing children. Expectant mothers who might give birth prematurely are often treated with an infusion of glucocorticoids. … Continue reading

Posted in Health Concerns, Pharmaceuticals |

FDA Orders Genetic Testing Firm to Cease DNA Analysis Service Sales


The U.S. Food and Drug Administration (FDA) has demanded 23andMe, a DNA testing service, to immediately stop selling and marketing its services until the agency gives the firm clearance to do so. The FDA is seeking to stop the sales … Continue reading

Posted in Defective Medical Devices, Defective Products, Health Concerns, Pharmaceuticals |

FDA Issues Drug Safety Statement Over Meridian Medical Technologies Auto-Injectors


The U.S. Food and Drug Administration (FDA) just announced that it has been made aware of a supply disruption of auto injectors for Atropen (atropine),
DuoDote (atropine/pralidoxime chloride),
morphine sulfate,
pralidoxime chloride, and 
diazepam. The auto injectors involved are manufactured by Meridian Medical … Continue reading

Posted in Pharmaceuticals |

Diabetes Drug-Pancreatitis Link Supported in Another Study


Another study has made a connection between Type 2 diabetes drugs known as incretin mimetics and increased rates of developing pancreatitis, a known precursor to pancreatic cancer. Incretin mimetics, are GLP-1-based diabetes therapies and include Byetta and Bydureon (exenatide); Victoza … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Amgen’s Aranesp Claims Get FDA Attention for Overstating Benefits, Minimizing Risks


The U.S. Food and Drug Administration (FDA) just wrote to drug maker, Amgen Inc., about misleading marketing claims concerning its anemia drug, Aranesp (darbepoetin alfa). The letter, not quite as serious as an agency warning letter, scolded the drug maker … Continue reading

Posted in Pharmaceuticals |

Cameras Catching Nursing Home Abuse Lead to Controversy


Nursing home abuse is among the most devastating of horrors targeting our older, vulnerable loved ones. Recently, a case in which a small camera—meant to catch a petty thief—caught a loved one being abused and taunted, increasing awareness of both … Continue reading

Posted in Legal News, Nursing Home Abuse |

© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.